Bioq Devices Pty LTD

bioq devices is a pre-clinical stage medical device company developing patented extra aortic balloon counterpulsation technology that targets drug resistance hypertension and moderate heart failure suffers. over 5 million patients suffer heart failure in the usa alone and at least 1 million of this group are suitable for treatment using the bioq cardiac assist system. the minimum global market opportunity for the bioq cas has been valued at over usd$1 billion/year and is estimated to grow in excess of the crt/d market of $3b pa. the device can be used to treat hypertension and targets the additional market opportunity of 24% of the 73 million people in the united states with inadequate control of their hypertension. the self-powered extra aortic counterpulsation system being developed by bioq, treat’s heart failure by reducing afterload and increasing coronary artery blood flow, using the proven principles of aortic counterpulsation delivered in a new revolutionary approach that is aim